FDA Inspection 1177446 — American National Red Cross Blood Services SW Region
The FDA completed an inspection of American National Red Cross Blood Services SW Region on July 15, 2022 in Tulsa, OK. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 15, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Tulsa, OK (United States)